Other languages Adherium Limited

Equities

ADR

AU000000ADR1

Market Closed - Australian S.E. Other stock markets 01:55:35 2024-05-29 am EDT			5-day change	1st Jan Change
0.017 ^AUD	-5.56%		-10.53%	-69.64%

May. 24	Adherium Partners with AstraZeneca for Hailie Smartinhaler Trial	MT
May. 23	Adherium Raises Nearly AU$7 Million from Entitlement Offer	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Adherium Seeks to Raise AU$8.4 Million Via Placement, Entitlement Offer; Shares Fall 24%	Apr. 26
Adherium’s Hailie Smartinhaler Secures FDA Approval for Use with AstraZeneca's Airsupra and Breztri Inhalation Devices	Apr. 14
Adherium Signs Partnership Deal with Rimidi for Asthma Medication	Apr. 02
Adherium Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28
Adherium Limited Announces Resignation of Rick Legleiter as Chief Executive Officer	Jan. 15
Adherium Limited Appoints Lou Panaccio as Executive Chairman of the Board	Jan. 15
Adherium Completes Initial Delivery of Hailie Smart Inhaler Sensors to US Intermountain Health; Shares Jump 6%	Dec. 17
Adherium Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30
Adherium Signs Deal to Integrate Respiratory Platform with US Partner	23-08-04
Adherium Limited Announces Resignation of Mark Licciardo as Joint Company Secretary	23-07-06
Adherium Limited Announces Executive Changes	23-05-03
Adherium Secures US FDA Clearance for Use of Sensor on Teva Inhalers	23-03-23
Adherium Limited Receives U.S. FDA 510(k) Clearance for Teva's Proair® and Albuterol Sulphate Inhaler Users to Remotely Monitor Physiological Parameters	23-03-22
Adherium Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-26
Adherium Limited Commences Production and Market Release of the New, Next Generation Ellipta Sensor	23-01-19
Adherium Secures Healthcare Monitoring Contract in the UK	23-01-18
Adherium Wins UK NHS SBRI Healthcare Monitoring Project	23-01-17
Adherium Announces James Ward-Lilley Step Down from the Board	22-11-29
Adherium Limited Receives U.S. FDA 510(k) Clearance for GSK pMDI Inhaler Users to Remotely Monitor Physiological Parameters	22-11-27
Adherium Limited Auditor Raises 'Going Concern' Doubt	22-09-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Adherium Limited

Equities

ADR

AU000000ADR1

Other languages

Filters